Table: Pharmarise Holdings - 9-MTH group results

Pharmarise Holdings

12/04/2019 09:00

Apr 12 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended        Year to  
                  Feb 28, 2019        Feb 28, 2018      May 31, 2019  
                     LATEST             YEAR-AGO           LATEST     
                     RESULTS             RESULTS          FORECAST    
  Sales               38.51               40.94             52.50     
                   (-5.9 pct)          (+7.9 pct)        (-3.8 pct)   
  Operating          281 mln             958 mln           395 mln    
                   (-70.6 pct)        (+252.6 pct)       (-66.5 pct)  
  Recurring          218 mln             890 mln           270 mln    
                   (-75.4 pct)        (+387.2 pct)       (-75.3 pct)  
  Net             loss 110 mln           238 mln        loss 205 mln  
  EPS            loss 12.14 yen         26.36 yen      loss 22.41 yen 
  EPS Diluted                           25.51 yen                     
  Ann Div                               14.00 yen         14.00 yen   
  -Q2 div              NIL                 NIL                        
  -Q4 div                               14.00 yen         14.00 yen   
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T